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SUMMARY:
Introduction:Despite the eight decades of widespread
clinical use of formocresol growing evidence from both
experimental and clinical studies clearly indicates that
formaldehyde is leaking out during pulpotomy and may
participate in the development of non-target tissue damage of
local and systemic character. Special attention has been paid
to pulp-capping materials and especially mineral trioxide
aggregate (MTA) as probable alternative of formocresol in
vital pulpotomy in primary teeth, in line with its excellent
biocompatibility and pro-dentinogenic properties. The
overwhelming evidence that MTA is superior in terms of
biological compatibilityand clinical success as compared to
formocresol has conditioned the dramatic shift to MTA in
routine pulpotomies.
Objective: The aim of this study was to assess the
biocompatibility of resorcinol/formalin (RF) pulpotomy
preparation in comparison to mineral trioxide aggregate
(MTA) and calcium hydroxide cement (CHC).
Methods: Cell survival was assessed by the MTT-
assay (after 48, 72 or 144 h) in five cell lines, namely: HD-
MY-Z, HEK-293, SH-SY-5Y, Neuro-2A, SaOS-2.  In addition
treatment-induced morphological perturbations and induction
of necrosis and apoptosis were assessed in HEK-293.
Results: RF evoked strong, concentration-dependent
cytotoxicity, which was evident even at significant dilution
of the parent solution. In general the cytotoxicity of RF was
not greatly influenced by the exposure period, especially at
the higher concentrations under evaluation. In contrast the
MTA extracts proved to be generally devoid of cytotoxic
effects. MTA treatment actually increased the viability of
SaOS-2 osteosarcoma cells, which could be attributed to the
presence of calcium ions in the MTA-eluate which in turn
stimulates the proliferation of this cell line.The CH cement
extracts showed marginal cytotoxicity which was far less
pronounced than that of RF and slightly superior compared
to MTA.
Conclusions: In contrast to RF that exerted prominent
cytotoxicity, MTA and CHC were biocompatible, with no
evidence for decreased mitochondrial dehydrogenase activity,
morphological changes in monolayer integrity or induction of
apoptosis and/or necrosis. This contribution is the first
systematic in vitro evaluation of the cytotoxicity of resorcinol-
formalin vs. viable pulpotomy agents. It gives further evidence
for the safety advantages of viable pulp therapy products CHC
and especially MTA as compared to the RF preparation,
routinely used in Bulgaria for decades.
Key words: pulpotomy, formaldehyde, resorcinol,
MTA, biocompatibility, calcium hydroxide, cytotoxicity,
MTT-assay, apoptosis, necrosis.
INTRODUCTION
Worldwide, formaldehyde-based products continue to
be used routinely in dentistry (1). Most dental schools in
Europe, North America and elsewhere still widely advocate
the dominant clinical use of formocresol (a m-cresol/
formaldehyde based product) pulpotomies in both carious
primary and permanent teeth (2-4). In Eastern Europe, and
Bulgaria in particular, primary tååth pulpotomies are
performed employing a chemically analogous and
therapeutically equivalent protocol based on a saturated
resorcinol solution in formalin (RF), instead for formocresol
(5-8).
Despite the eight decades of widespread clinical use
of formocresol growing evidence from both experimental and
clinical studies clearly indicates that formaldehyde is leaking
out during pulpotomy and  may participate in the development
of non-target tissue damage of local and systemic character
(1, 9, 10). This has been argued by some authorities who
consider formocresol to be devoid of significant toxicity in
humans when applied in low doses (i.e. in pulpotomies) (1,
11, 12). Regardless, the immunologic and systemic
distribution of 14C labeled formaldehyde has been well
documented (13, 14) and the toxic effects of formocresol and  / JofIMAB; Issue: 2012, vol. 18, book 2 /  201
other formaldehyde containing agents have been clearly
demonstrated in vivo and in vitro (9, 10, 15-23). Recent
clinical data evidently reinforce these observations (2, 4, 10,
13, 24).
The evidence obtained shows that formocresol even
in reduced concentrations has the potential to result in
negative immunologic, systemic, toxicological, and overt
clinical consequences. More specifically formaldehyde
employed during pulpotomy could evoke inflammation of
surrounding non-target tissue and exert cytotoxic (16, 17,
21, 23), genotoxic and mutagenic effects (9, 19) leading to
tissue damage ranging from vascular insult and inflammation
(3, 4, 25) to necrotic (26, 27) and osteolytic changes (13).
It is also capable of damaging the enamel and the
succedaneum teeth (17). Moreover the pulpal proteins that
have been treated by the formocresol or formalin/resorcinol
are rendered by the host as an altered entity, recognized as
potentially antigenic and immunologically foreign. Thus in
addition to the local, non-specific inflammatory events
evoked by formocresol the host’s immune system could be
sensitized to the treatment-modified materials. These could
be in turn phagocytized by macrophages, enzymatically
processed by neutrophils and stimulate the generation of B
and T-cell immune response (13). This is further complicated
by the overlying immunologic response to the bacteria and
its by-products from the carious lesion that the treatment is
supposed to remove and by non-specific stimulation of
innate immunity mechanisms and cytokine production (13,
25, 28). Besides, the genotoxic, carcinogenic and mutagenic
potential of formaldehyde has been so extensively
appreciated to be regarded as proven (9, 13, 19, 20, 22, 29).
The International Agency for Research on Cancer classified
formaldehyde as definitely carcinogenic for humans in June
2004, leaving the profession to look for alternative regimens
(30). On the basis of the information available, an expert
working group has concluded that there is now sufficient
evidence that formaldehyde causes nasopharyngeal cancer
in humans, a rare cancer in developed countries, limited
evidence for cancer of the nasal cavity and paranasal sinuses,
and “strong but not sufficient evidence” for leukemia (4, 30).
Therefore, biologic manifestations of a simple formocresol
pulpotomy could well extend beyond the transient local
events and can be significant and potentially systemically
harmful to a patient (2-4, 24).
Apparently the above stated evidence-based dentistry
has provided overwhelming scientific and clinical data to
support the removal of formocresol from human use
especially in the pediatric population (10, 13). Thus during
the last several years the clinical role of formocresol has
been subject to significant clinical debate and reevaluation
(1, 10). It has been shown that many clinical studies
supporting the use of formocresol have been based on old,
imprecise, short-term data (2-4, 10, 24). On these grounds
many clinicians in Western Europe and North America tend
to be increasingly reluctant regarding the usefulness of
formocresol. Thus in a survey in Great Britain it has been
shown that 54% of the pediatric dentists stated they were
concerned about the safety profile of formocresol.
Conversely, in an USA study 37% of endodontists and 18%
of the pediatric dentists were concerned about the
carcinogenicity of formocresol (13).
As a result of this compelling evidence, there has been
a rigorous and diligent effort to design and elaborate
alternative materials and procedures for use in pulpotomies
(4, 31-33). Ideally such agents would guarantee the radicular
pulp preservation in primary teeth until the time of their
physiological exfoliation, while at the same time avoiding the
side effects and  long term toxicities from formaldehyde-
containing medicaments. The most important medicaments
and procedures studied in primary teeth pulpotomy include
electrosurgery, laser, glutaraldehyde, ferric sulphate, freeze-
dried bone, bone morphogenic protein and osteogenic protein,
among others (2-4, 15, 24). Recently, advances in biomedical
research opened avenues for the design of new methods of
dental treatment, aiming at regeneration of the dentin-pulp
complex. Such approaches have been based on the
understanding of the molecular and cellular mechanisms
regulating the dentinogenesis processes during dental tissue
repair and their potential for clinical exploitation (2, 4, 10,
31). Accordingly, the research focus has been re-targeted from
preservation and conservation to regeneration of the
remaining pulp tissue (3, 4, 31, 32, 34-36). In this context
special attention has been paid to pulp-capping materials and
especially mineral trioxide aggregate (MTA) as probable
alternative of formocresol in vital pulpotomy in primary teeth,
in line with its excellent biocompatibility and pro-
dentinogenic properties (32, 34, 37-49). The overwhelming
evidence that MTA is superior in terms of biological
compatibility (18, 28, 39, 41, 47, 50-53) and clinical success
as compared to formocresol (2, 3, 24, 33-36, 45, 53-64) has
conditioned the dramatic shift to MTA in routine pulpotomies
(2-4, 31-36, 55, 61). Nevertheless, one must continue to
ascertain the in vitro properties, long-term efficacy, biological
and clinical use of MTA.  Moreover there are alternative
capping agents (e.g. Portland cement, calcium hydroxide and
calcium silicate based cements etc.), which could be regarded
as possible cheaper alternatives for MTA (4, 45, 58), requiring
for further experimental and clinical research and evaluation.
Despite the cytotoxicity of formocresol has been subject to
numerous investigations the in vitro biosafety and
compatibility profile of resorcinol/formalin being the
dominant pulpotomy preparation in Eastern Europe is
generally unexplored. On these grounds this study is aimed
at thorough comparative evaluation of biocompatibility
profiles of the three regimens most often employed in primary
teeth pulpotomy in Bulgaria, namely resorcinol/formalin
solution for mortal pulp management, or calcium hydroxide
and MTA cements for vital pulp treatment.202  / JofIMAB; Issue: 2012, vol. 18, book 2 /
MATERIALS AND METHODS
Pulpotomy agents and solutions. Formulations of the
different agents were prepared in the laboratory according
to the composition of the different materials as used
clinically. The used chemicals were of reagent-grade quality,
obtained from licensed dental material supply companies.
The RF solution was prepared according to the
Bulgarian clinical protocol, as a saturated solution of
resorcinol into 40% aqueous formaldehyde (5, 6). It was
then diluted 1:1 with PBS to yield formaldehyde
concentration of ca. 20%, thus mimicking the HCHO content
in the most widely used Buckley’s formulation of
formocresol. Thereafter, for the bioassays the cells were
exposed to serial dilutions of the RF solution, namely 1:25,
1:100, 1:200 and 1: 1,000 in PBS. The selected
concentrations were either higher or lower as compared to
the clinically relevant level of exposure of non-target tissues,
corresponding to 1:100 formocresol (Buckley’s formulation)
(26, 65).
Two vital pulpotomy capping agents namely mineral
trioxide aggregate (MTA; white, Angelus Soluções
Odontológicas, Londrina, PR, Brazil) and Ca(OH)2 (CHC;
Dycal® Dentsplay) were used. They were prepared according
to the manufacturer’s instructions and after mixing, the
cements were stored in an incubator at 100% relative
humidity and 37°C for 1 day of hydration. The cements were
then sterilized in ultraviolet light for 1 hour and stored in
serum-free RPMI-1640 medium in a polypropylene tube for
3 days. The concentrations of the cement elution solutions
were adjusted to 1, 10, 30, and 100 mg/mL.
Cell lines and culture conditions. In this study the
following cell lines were used:, HD-MY-Z (Hodgkin
lymphoma, human), HEK-293 (human embryonal kidney
epithelium), SAOS-2 (human osteogenic sarcoma), SH-SY-
5Y (human neuroblastoma) and Neuro2A (murine
neuroblastoma). Except for HEK-293 and SH-SY-5Y, which
originated from American Type Cell Culture (ATCC), all cell
lines were obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ GmbH,
Braunschweig, Germany). The cells were grown in
controlled environment – cell culture flasks at 37oC in an
incubator ‘BB 16-Function Line’ Heraeus (Kendro, Hanau,
Germany) with humidified atmosphere and 5% CO2. HD-
MY-Z were cultured as semi-adherent, and the other cell
lines as monolayer cultures. SAOS-2 cells were grown in
85% McCoy’s 5A supplemented with 15% fetal bovine
serum (FBS), whereas for the other cells the growth medium
was RPMI-1640 supplemented with 10% (FBS) and 2 mM
L-glutamine. The cell lines were reset by trypsinization two
times per week.
MTT-dye reduction assay. Cell survival was assessed
by the MTT-dye reduction assay, which is based on the
ability of mitochondrial succinate dehydrogenases in viable
cells to reduce a yellow tetrazolium salt to violet formazan
product which is detected spectrophotometrically. The
procedure was carried out as previously described (66).
Exponentially growing cells were plated in 96-well sterile
plates at a density of 104 cells/well in 100 mL of medium
and were incubated for 24 h. Thereafter the cells were
exposed to serial dilutions of the resorcinol/formalin solution
or the cement extracts for 48, 72 or 144 h. For each
concentration a set of 8 wells was used.  After the exposure
period 10 mL aliquots from a 5 mg/ml MTT solution were
added to each well and the plates were further incubated for
4 h at 37°C in a humidified 5 % CO2 atmosphere. The
formazan crystals were solubilized by addition of HCOOH
(5 %) acidified 2-propanol. The MTT-formazan absorbance
was read on a microprocessor controlled micro-plate reader
(Labexim LMR-1). Results were normalized as percentage
of the untreated control (set as 100% viability).
Apoptosis/necrosis assay. The DNA fragmentation as
a quantitative merit of the ability of tested compounds to
induce cell death was detected using a commercially
available ‘Cell Death Detection ELISAPLUS’™ kit (Roche
Applied Science), after 12 or 24 h treatment of HEK-293
cells, according to the manufacturer’s instructions. The
levels of DNA-fragments in the cytosolic fraction of treated
cells (apoptotic fragmentation) and those in the culture
supernatants (necrotic) were presented as enrichment factors
(EF). These were calculated by dividing the 405 nm
absorption of treated samples by the corresponding
absorption of the untreated control. Each test was run in
triplicate.
Morphological assay. The 48 h MTT-assay treatment
protocol was mimicked in established confluent HEK-293
cell monolayers (cultured in sterile Petri dishes) in order to
register defects in the monolayer integrity and cellular
density, undetectable by the MTT-dye reduction assay. The
exposed cultures where examined by a phase-contrast light
microscope and photographed with a digital camera 48 h
post treatment.  The results were interpreted using the grade
scale, described in USP 28 (2005) (grades 0-4) for
assessment of the cytotoxic potential of tested materials, as
follows: grade 0 – none reactivity (discrete intracytoplasmic
granules, no cell lysis); grade 1 – slight reactivity (Not more
than 20% of the cells are round, loosely attached and without
intracytoplasmic granules; occasional lysed cells are
present); grade 2 – mild reactivity (not more than 50 % of
the cells are round and devoid of intracytoplasmic granules,
no extensive cell lysis and empty areas between cells); grade
3 – moderate (Not more than 70% of cell layers contain
rounded cells or are lysed); grade 4 -severe (nearly complete
destruction of the cell layers).
Data processing and statistics. The cytotoxicity MTT-
assay was carried out in eight separate experiments,
whereas the morphological, apoptosis/necrosis assays were
run in triplicate. Statistical processing exploited Student’s
t-test with pd≤ 0.05 set as significance level.  / JofIMAB; Issue: 2012, vol. 18, book 2 /  203
RESULTS
The cytotoxicity of the agents was assessed by the
MTT-dye reduction assay in a panel of cell lines,
representative for cellular populations that would have been
exposed to the chemical entities in pulpotomy medications
within a clinical situation, namely: HD-MY-Z (histiocytes/
fibroblasts), HEK-293 (epithelium), SH-SY-5Y and Neuro-
2A (neurons) and SaOS-2 (calcified tissue). The cell survival
after exposure to resorcinol/formalin (RF) solutions, or
eluate extracts from MTA or Ca(OH)2 cement (CHC) is
presented in figures 1,2 and 3 respectively.
RF evoked strong, concentration-dependent
cytotoxicity, which was evident even at significant dilution
of the parent solution (Fig. 1). At the highest concentration
tested (1:25 dilution) the cellular viability was greatly
decreased in all cell lines. In general the cytotoxicity of RF
was not greatly influenced by the exposure period, especially
at the higher concentrations under evaluation.
In contrast the MTA extracts proved to be generally
devoid of cytotoxic effects. Only slight decreases in cellular
viability were encountered at the highest concentration tested
after 48 h exposure in HEK-293, SaOS-2, and Neuro-2A
cells (Fig. 2). The same treatment intensity however, after
longer exposure was associated with less pronounced
decrease in cell viability. Noteworthy MTA treatment
actually increased the viability of SaOS-2 osteosarcoma
cells, which could be attributed to the presence of calcium
ions in the MTA-eluate which in turn stimulates the
proliferation of this cell line.
The CHC extracts showed marginal cytotoxicity
which was far less pronounced than that of RF and slightly
superior compared to MTA (Fig. 3). This could be due to
release of hydroxide ions during the extraction process and
pH-modulation in the culture environment. Noteworthy, the
effects of CHC were evident after 48 h exposure, but
invariably at longer exposure periods the cell survival
fractions tended to increase to values non-significantly
different from control group.
Fig. 1 A, B, C, D, E. Cytotoxicity of resorcinol/formalin (RF) in a panel of cell lines after continuous exposure as
assessed by the MTT-dye reduction assay.
Cellular viability following resorcinol/
formalin (RF) continuous exposure for
48,72 or 144 h, as assessed by the
MTT-dye reduction assay. Each
column represents the arithmetic mean
+ sd of  8 separate experiments.
Asterisks indicate statistically
significant differences as compared to
the untreated control (*p<0,05;
*p<0,01)204  / JofIMAB; Issue: 2012, vol. 18, book 2 /
Fig. 3 A, B, C, D, E. Cytotoxicity of calcium hydroxide cement extracts in a panel of cell lines after continuous
exposure as assessed by the MTT-dye reduction assay.
Fig. 2 A, B, C, D, E. Cytotoxicity of MTA extracts in a panel of cell lines after continuous exposure as assessed by
the MTT-dye reduction assay.
Cellular viability following MTA
eluate continuous exposure for 48,72
or 144 h, as assessed by the MTT-dye
reduction assay. Each column
represents the arithmetic mean + sd of
8 separate experiments. Asterisks
indicate statistically significant
differences as compared to the
untreated control (*p<0,05; *p<0,01)
Cellular viability following resorcinol/
formalin (RF) continuous exposure for
48,72 or 144 h, as assessed by the
MIT-dye reduction assay. Each column
represents the arithmetic mean + sd of
8 separate experiments. Asterisks
indicate statistically significant
differences as compared to the
untreated control (*p<0,05; *p<0,01)  / JofIMAB; Issue: 2012, vol. 18, book 2 /  205
The MTT-data where corroborated by a morphological
evaluation of established HEK-293 monolayers after 48 h
treatment. Evident from the results summarized in Table 1 and
Fig. 4 MTA or CHC  extracts failed to induce any detectable
changes relative to the control group, throughout the evaluated
Table 1. Morphological assessment of the cytotoxic effects of the tested pulpotomy agents against established HEK-
293 monolayers after 48 h exposure.
Treatment series Cytotoxicity grades1
Resorcinol/formalin 1:25 1:100 1:200
Grade 4 Grade 3 Grade 1
Mineral trioxide aggregate 100 mg/ml 30 mg/ml 10 mg/ml
Grade 0 Grade 0 Grade 0
Calcium hydroxyde cement 100 mg/ml 30 mg/ml 10 mg/ml
Grade 0 Grade 0 Grade 0
1According to USP28: Grade 0 – None reactivity; Grade 1 slight reactivity; Grade 2 – Mild reactivity: Grade 3 –
Moderate reactivity; Grade 4- Severe reactivity (Described in detail in the Materials and methods section).
concentration range, while cytotoxic RF proved to greatly
affect the monolayer integrity, lower the cell density, and at
the highest concentration applied evoked prominent signs of
cytotoxicity (rounded cells, detached cells and signs for
disruption of membrane integrity).
Fig. 4. Representative phase contrast microscopic imaging of HEK-293 monolayers: (A) untreated control; (B) 48
h exposure to 100 mg/ml MTA extract; (C) 48 h exposure to 100 mg/ml CHC extract;  (D) 48 h exposure to  RF 1:100
dilution; (E) 48 h exposure to  RF 1:25 dilution;  (F) 48 h exposure to RF 1:25 dilution (higher magnification).
concentration and duration was consistent with a gradual
increase in the proportion of necrotic cells. In a dissimilar
fashion both MTA and CHC failed to induce significant
increase of the DNA-fragmentation in either cytosolic
fraction or supernatants, relative to control samples (data not
shown), indicating that the observed decreased survival
fractions in the MTT-assay could be solely attributed to
antiproliferative rather to direct cytotoxic properties.
The biocompatibility of tested pulpotomy agents was
further explored using a commercially available ‘Cell death
detection ELISAPLUS’ kit allowing simultaneous
quantification of apoptotic and necrotic cell death. As shown
by the results obtained (fig. 5) RF was a potent inducer of
both types of cell death, in relation to concentration and
treatment duration. Thus at lower levels and shorter exposure
apoptosis was the dominant type of cell death in tested
samples, whereas the intensified exposure in terms of both206  / JofIMAB; Issue: 2012, vol. 18, book 2 /
Fig. 5. Induction of apoptotic and necrotic cell death following 12 h or 24 h exposure to different dilutions of resorcinol/
formalin (RF) as assessed by ‘Cell death detection ELISAPLUS’™ kit, according to the manufacturer’s instructions. Each test
was run in triplicate. Asterisks indicate statistical significance vs. the untreated control (* pd≤  0.05; ** pd≤  0.01). The results
are presented as enrichment factor (EF) calculated as the 405 nm absorption of treated samples relative to that of untreated
controls, set as 1 (Described in detail in the Materials and methods section).
When we assessed the proliferation/viability of human
cells exposed to MTA extract solution, we found that the MTA
was associated with less prominent inhibitory effects than
calcium hydroxide. It is well appreciated that toxic
compounds within dental materials can initiate adverse
reactions in surrounding periodontal tissue. Although MTA
and CH cement are biocompatible, they are still foreign to
the tissue. The discrepancy between the extracts activity could
be due to the composition of cements – MTA is composed
of hydrophilic particles and contains tricalcium silicate,
tricalcium aluminate, tricalcium oxide, silicate oxide, and
other mineral oxides, which set in the presence of moisture
(32), whereas the other cement is composed of calcium
hydroxide solely (4). The latter has prominent alkaline
properties and  despite its very low water solubility is still
capable of significant release of hydroxide ions (75). The
latter could have an adverse effect on the pH
microenvironment of cultured cells contributing to the
observed effects in the MTT-bioassay. In contrast MTA is
composed of insoluble silicates and oxides and is less prone
to releasing ions other than calcium, the latter being obviously
non-toxic within the chosen experimental conditions. These
data generally corroborate the superior biosafety profile of
MTA vs. calcium hydroxide (18, 76).
Overall, the findings from the MTT-assay corroborate
preceding reports which have shown that MTA and CHC are
biocompatible with many cell lines (23, 32, 34, 37-42, 46,
50). In contrast some studies have shown some albeit low-
grade cytotoxicity of MTA (71, 77) but this discrepancy with
our results could be attributed to the experimental design and
the cell lines evaluated. In a biocompatibility study, the
material tested can be in either direct or indirect contact with
the target cellular population. In the present study we analyzed
the bioactivities of the MTA or CHC  in an indirect contact
with the cells for 2, 3 or 6 days. A proliferation study
involving direct contact between the cultured cells and the
DISCUSSION
The present study showed that in contrast to RF, that
proved to be cytotoxic throughout a range of concentrations
and exposure periods, the MTA and CHC  were
biocompatible, with no evidence for decreased mitochondrial
dehydrogenase activity, morphological changes in monolayer
integrity or induction of either apoptotic or necrotic cell death.
RF proved to be highly cytotoxic causing time- and
dose-related perturbation in cellular viability of all tested cell
lines. Noteworthy cytotoxicity was detected even at the 1:100
dilution which is considered clinically relevant (65). These
data well correlate to the well-established toxicity of the
similar mortal pulpotomy agent formocresol (12, 15-19, 21-
24) formaldehyde being the major constituent of both. The
second ingredient resorcinol could at least partly contribute
to the observed effects, as its intrinsic antiproliferative/
cytotoxic properties have been well documented (67-70). The
relative role of the phenolic component however, is at best
moderate, as it has been well documented that formaldehyde
is 20 times as cytotoxic as m-cresol (17).
MTA and CHC had only marginal effects on
mitochondrial succinate dehydrogenase, detected only at 48
h. With increased exposure the viability of tested samples was
no significantly different as compared to the untreated control.
This particular response can be attributed to the presence of
a non-responsive pool of cell population whose proliferative
activity remained unaffected allowing the cell culture to repair.
These observations for reversible inhibitory effects of MTA
also support those described previously by others (71-73).
An issue of special interest is the stimulatory activity
of MTA regarding SaOS-2 neuroblastoma, which could be
attributed to the ions released form MTA, during the
extraction process providing an optimum amount of calcium
for cell proliferation. These data corroborate the well-
established osteoinductive and dentinogenic properties of
MTA (45, 47, 53, 62, 74).  / JofIMAB; Issue: 2012, vol. 18, book 2 /  207
freshly mixed cements would have been less meaningful,
because cultured cells lack the restorative mechanisms of
living tissues (78). Thus most probably the lower survival rate
at various concentrations with both the MTA and CHC
encountered in preceding studies is due to the employment
of direct contact experimental set-up.
The morphological study conducted according to USP
XXVIII further supported the significant cytotoxicity of FC
and the lack of bio-reactivity of the cement-extracted eluates.
These findings further evidence that the marginal inhibitory
effects of CHC or MTA documented in the MTT-assay are
due to slight inhibition of proliferation without direct
cytotoxicity.
The in vitro cyto-compatibility testing with cell culture
systems, commonly uses cell death based end-point, although
they do not differentiate between the mechanistic aspects
involved. Cell death is executed by two major mechanisms
and correspondingly distinct signaling pathways (apoptosis
and necrosis). Apoptosis is a major form of cell death, and it
is an important process in a variety of different biological
systems, embryonic development and in chemically induced
cell death, while generally necrosis is initiated by significant
suppra-physiological chemical and/or physical stimuli.
Besides the mechanistic differences, at morphological level,
necrosis is quite different from apoptosis, as well. During the
necrotic process, the cells first swell, then the plasma
membrane collapses, and subsequently, the cells are rapidly
lysed, whereas in apoptosis cells are transformed into
apoptotic bodies, without perturbation of the membrane
integrity (79). An issue of concern regarding the relative
importance of the cell death mechanisms is that while the
interaction between apoptotic and phagocytic cells induces an
anti-inflammatory response, necrosis appears to be critical for
the initiation of inflammatory, innate- and specific immune
responses (79, 80).
Taking into account the above considerations we
performed an apoptosis/necrosis discriminating assay in HEK-
293 cells using an array of concentrations, higher or lower
relative to that found in adjacent non-target tissue in
endodontic or pulpotomy procedures tissue (equivalent to
1:100 formocresol dilution). Our observations showed
simultaneous activation of necrotic and apoptotic pathways
leading to cell death within the same target cellular population
after 12 to 24 h exposure, whereby the prevalence of apoptotic
and especially necrotic mechanisms was dependent on dose
and exposure duration.  The MTA and CHC extracts proved
to be devoid of apoptosis- or necrosis-inductive properties
which further evidences for their superior safety profile as
compared to RF. These findings are in agreement with
previously published data for the ability of formocresol to
trigger apoptotic and necrotic cell death in cultured cells (26),
and for the lack of pro-apoptotic activity of mineral trioxide
aggregate (37, 51, 52).
CONCLUSIONS
Advances in evidence-based dentistry and dental
material science have gained enough evidence to support the
notion that the application of formaldehyde-based products
in pediatric dentistry albeit widespread is unwarranted
because of safety concerns, and consequently, their use in
pediatric pulp therapy is obsolete. As a result, numerous
investigations for alternatives to formaldehyde/phenol
devitalization medicines, some of which have shown efficacy
equivalent or even superior to formocresol, have been
completed. This contribution is to the best of our knowledge
the first systematic, multiple end-point, in vitro evaluation of
the cytotoxicity of resorcinol-formalin vs. vital pulpectomy
capping agents. It gives further evidence for the
biocompatibility and safety advantages of viable pulp therapy
products calcium hydroxide cement and especially MTA as
compared to the resorcinol/formalin preparation, routinely
used in Bulgaria for decades.
There can be no doubt that from a 21st century
perspective a reparative, biologic, and patient-friendly
approach to pediatric pulp therapy is preferable to the
absolutist, devitalization approach of resorcinol-formalin
primary tooth pulpectomy, and the replacement of the latter
by clinically superior and safer alternatives is not only
welcome but absolutely indispensable.
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